Skip to main content

Halozyme Therapeutics, Inc. - Common Stock (NQ: HALO )

48.06 +0.03 (+0.07%)
Streaming Delayed Price Updated: 9:47 AM EST, Dec 27, 2024 Add to My Watchlist

Insider Filings

Form 4/A
Source: SEC/Edgar
March 19, 2007
Form 4
Source: SEC/Edgar
March 15, 2007
Form 4
Source: SEC/Edgar
March 15, 2007
Form 4
Source: SEC/Edgar
March 15, 2007
Form 4
Source: SEC/Edgar
March 14, 2007
Form 3
Source: SEC/Edgar
February 25, 2007
Form 5
Source: SEC/Edgar
February 08, 2007
Form 4
Source: SEC/Edgar
February 06, 2007
Form 4
Source: SEC/Edgar
February 06, 2007
Form 4
Source: SEC/Edgar
February 06, 2007
Form 4
Source: SEC/Edgar
February 06, 2007
Form 4
Source: SEC/Edgar
February 06, 2007
Form 4
Source: SEC/Edgar
February 06, 2007
Form 4
Source: SEC/Edgar
December 19, 2006
Form 3
Source: SEC/Edgar
December 14, 2006
Form 3
Source: SEC/Edgar
December 14, 2006
Form 4
Source: SEC/Edgar
December 10, 2006
Form 4
Source: SEC/Edgar
December 05, 2006
Form 3
Source: SEC/Edgar
November 12, 2006
Form 4
Source: SEC/Edgar
September 17, 2006
Form 4
Source: SEC/Edgar
September 12, 2006
Form 4
Source: SEC/Edgar
September 07, 2006
Form 4
Source: SEC/Edgar
August 28, 2006
Form 4
Source: SEC/Edgar
August 23, 2006
Form 4
Source: SEC/Edgar
August 20, 2006
Form 3
Source: SEC/Edgar
August 16, 2006
Form 5
Source: SEC/Edgar
August 14, 2006
Form 4
Source: SEC/Edgar
August 14, 2006
Form 5
Source: SEC/Edgar
August 14, 2006
Form 5
Source: SEC/Edgar
August 14, 2006
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.